Aestimo Innovator’s Briefings (AIB)

A global innovation map focused on patient-need, designed to inform and enable all healthcare innovation stakeholders to determine validity, competitive value and investment requirement for a better healthcare, everywhere.

Each report contains

 

  • Continental region-specific indication prevalence and incidence rates (the latter, region specific or global) for either:

                     -European Union

                     -North America

                     -Latin America and the Caribbean

                     -Africa and the Middle East

                     -Asia

 

  • The Standards of Care:

                     -Class

                     -Application within the eligible patient population

                     -Examples

                     -Treatment cost based upon treatment regimen and region-specific

                      intervention price

 

  • The annual maximum market value of the classes of intervention within the specific geography (Serviceable Available Market – SAM value)

 

  • Forecasting (lifetime Serviceable Obtainable Market – SOM value) for the generation of a new product in each class, that would be better than the standard of care and sold at the same price to enable reimbursement

 

  • Lifetime revenue requirements necessary to achieve a Return on Investment via de novo development or repositioning of an existing validated intervention

 

  • De Novo and Repositioning Risk assessment for the development of the new product, generic or biosimilar in the region-specific marketplace

 

  • HTA/Health economics and patient reported outcomes overview of the components that determine if a new solution is reimbursable compared to the standard of care  

 

  • Overview of key characteristics of the disease

 

  • The patient journey from symptoms, through diagnosis and treatment to follow up

 

  • Ongoing global development statistics in the specific indication

 

  • Ongoing global clinical trial design metrics (median patient number, median duration and median cost)

 

  • References and recommended reading

 

Each report costs €50 (VAT excluded)

 

If you have any questions, please contact Jonathan at jdando@aestimo.ie

Oncology

cancer2.jpg

Female Reproductive Health

female reproductive health2.jpg
  • 19 types

coming soon

Urinary Tract 

urinary tract2.jpg

coming soon

Digestive

digestive2.jpg

coming soon

Diabetes

diabetes2.jpg

coming soon

Musculoskeletal

musculoskeletal2.jpg

coming soon

Respiratory

respiratory2.jpg

coming soon

CVD

cvd2.jpg

coming soon

Neurological & Sensory

coming soon

Mental Health

mental health2.jpg

coming soon

Suite 7, The Courtyard, Carmanhall Road, Dublin, D18 NW62

CRO Number 648128

Unknown.png

© 2019 by Aestimo Ltd.. Proudly created with Wix.com